Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

Edward Hurtte, MD

&

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease

Janki Luther, MD, MPH

Please Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for Zoom Details